Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a "Window Trial" of Cannabidiol (CBD) For Breast Cancer Primary Tumors

NCT06148038 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT06148038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06148038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a "Window Trial" of Cannabidiol (CBD) For Breast Cancer Primary Tumors
Lead sponsor
Medical University of South Carolina
Phase
Phase 1
Overall status
Recruiting
Start date
September 18, 2026
Completion date
August 28, 2031
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer